Stablepharma’s mission to eliminate the cold chain – an interview by Health Tech World

Stablepharma and BB-NCIPD Ltd (Bul Bio) Accelerate Vaccine Development with Collaboration

Stablepharma completes the first close of Series A raise with £2 million following a number of high-profile partnership announcements

Alan Boyd, of Boyd Consultants & Advisor to Stablepharma, talks about his work, collaborations and the impact of the Pandemic

Özgür Tuncer CEO talks about Developing Thermostable Vaccines To Improve Accessibility Worldwide

Stablepharma partners with the University of Strathclyde to advance their COVID mRNA vaccine thermo-stabilisation technology

Stablepharma appoints Professor Saul Faust to the Advisory Board

Stablepharma Response

Stablepharma awarded £50,000 as part of UK research and innovation program

Stablepharma and BB-NCIPD collaborating on Td vaccine

Can chemistry thaw the vaccine cold chain?

Innovate UK Smart Grant awarded to vaccine stabilising company